Dataset opportunity
Quantumsurgical — 医疗影像数据集机会
由 Quantumsurgical 持有的大型医疗影像数据集，可用于诊断AI和计算机视觉。
Score
73.5
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
71%
Action
数据共享协议
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market
全球基于AI的医疗影像市场 = 2024年32.8亿美元，复合年增长率45.68% (2025-2033)
Recent dated external facts that triggered this opportunity — auditable provenance.
- 📰press2026-06-04
Can surgical robots fly? SS Innovations discusses challenges, solutions
therobotreport.com ↗ - 📰press2026-06-04
Medtronic seeks clearance for Hugo surgical robot in more indications
medtechdive.com ↗ - 📰press2026-06-02
Petal Surgical adds more funding for incisionless surgical robot
therobotreport.com ↗
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
- ✨Signal
明确的健康数据仓库（HYGIE）用于研究和机器人改进
source ↗
Profile
Dataset profile
Type
医疗影像数据集
Modality
图像
Sector
医疗保健
Volume
大
Freshness
实时
Rarity
中等
Accessibility
受限
Legal
公司所有 — GDPR敏感（个人身份信息审查）
Buyer persona
医疗AI和诊断影像公司
Quantumsurgical 拥有一个医学影像数据集（图像模态），包含来自 data_catalog、downloads、image_collection、iot_data 和 medical_records 等多种来源的数据。这个丰富多样的数据集对于训练和验证诊断AI模型极具价值，能够开发用于疾病检测、图像分割和异常识别等任务的算法。数据的全面性，包括患者记录，增强了其在创建可提高诊断准确性和治疗计划的复杂AI解决方案方面的实用性。
基于AI的医学影像市场正在经历快速增长，2024年估值为32.8亿美元，预计到2033年将达到968.2亿美元，2025年至2033年的复合年增长率（CAGR）为45.68%。这一显著的市场扩张凸显了对高质量医学影像数据的巨大需求，以推动AI发展，其驱动力在于解决放射科医生短缺和提高诊断准确性的需求。尽管此健康相关且假名化数据在GDPR合规性和数据治理方面存在复杂性，并且Precision IO Group Inc.可能参与许可决策，但此类数据集在推动诊断AI方面的稀有性和关键重要性使其极具价值。⚠ 尽职调查（有价值的数据，可协商访问）：数据与健康相关且经过假名化处理，需要严格遵守GDPR并进行数据治理；数据许可决策可能可能涉及母公司Precision IO Group Inc. · 公司：Precision IO Group Inc.的子公司。
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
Quantumsurgical 拥有一套强大的假名化医学影像数据，这些数据直接与机器人辅助介入放射学程序相关联，特别是用于肿瘤治疗和特征描述。该数据集非常适合诊断AI开发，为医疗AI和诊断影像公司提供了在快速扩张的全球AI医学影像市场中进行创新的关键资源，该市场在2024年估值为32.8亿美元，复合年增长率为45.68%。数据来源于先进的机器人系统，并安全存储在经监管批准的健康数据仓库中，这确保了其技术深度和合规性，为即时评估提供了引人注目的机会。
See dimension details ↓- Dataset Specificity90
主导“医疗记录”，医疗保健领域，3种特定类型
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity58
专有领域数据（开放会降低稀有性）
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume88
9个证据命中
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness82
实时/流式传输
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value84
适用于诊断AI
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand95
全球医学影像AI市场，受诊断AI对医学影像数据集需求的驱动，预计将从2024年的约17.5亿美元增长到2030年的85.6亿美元，复合年增长率呈
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility14
开放/API访问
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility33
中等难度，Precision IO Group Inc.的子公司
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength98
5种证据类型，9个命中
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License62
所有权=自有，许可=GDPR敏感
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence50
Precision IO Group Inc.的子公司
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation39
1个数据需求信号（1种类型）
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
盈余=高，3个近期外部信号 — 超出已货币化的专有数据
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit100
✓ 良好目标 — Quantum Surgical 是一个极佳的目标，因为他们是一家在医疗机器人领域拥有实际运营业务的中小企业，作为副产品生成有价值的专有医学影像数据，目前他们将其用于内部研究和产品改进，而非出售。
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Medical records / imaging
这一关键证据证实了假名化健康数据的存在，包括关于治疗器官、病变特征和介入类型等详细信息，这些数据直接来源于使用其屡获殊荣的Epione机器人进行的介入放射学程序。这些数据对于训练专注于肿瘤分析和治疗结果的诊断AI模型高度相关。
Downloads / exports
此证据证实了Quantumsurgical关于经皮肌肉骨骼手术中机器人辅助的公开文档，表明其在介入医学方面的专业知识和技术重点，为所收集的数据提供了宝贵的技术背景。
IoT / sensor data
此证据表明Epione机器人在手术过程中收集了时间序列数据，并与患者医疗文件整合在一个中央健康数据仓库中。这为程序动态和机器人性能提供了独特的见解，补充了诊断影像，以实现全面的AI解决方案。
Image collection
此证据明确详细说明了Epione系统用于肿瘤边缘定义和手术规划的2D和3D图像（可能是CT扫描）的收集。这直接支持了用于精确肿瘤学应用和图像引导介入的诊断AI的开发。
Data catalog / marketplace
此证据证实了HYGIE的运营，这是一个经监管批准的健康数据仓库（CNIL决定DT2023-015），它集中了各种数据类型。这表明Quantumsurgical致力于数据治理和合规性，显著降低了AI买家获取数据的风险。
Marketplace
Dataset details
Geographic coverage
Global
Time range
Real-time
Update frequency
Real-time
Delivery
API
Formats
DICOM, JSON
License
One-time license for training and validation of Diagnostic AI models. Usage restrictions may apply to commercial deployment without further agreement.
Personal data
Contains PII
Indicative estimate, derived from public signals — not a quote, not contractual, and not agreed with the company. Is this your company? Correct it.
This dataset's value is driven by its large volume of pseudonymized medical imaging data linked to robotic-assisted interventional radiology procedures for tumor treatment, catering to the high-growth Diagnostic AI sector. The strong market demand, evidenced by the AI-based medical imaging market's rapid CAGR, supports a premium valuation.
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Quantumsurgical Medical Imaging — a Large medical imaging dataset (Image modality) in the healthcare domain. Primary AI use-case: Diagnostic AI. Market signal: Global AI-based medical imaging market = $3.28B in 2024, CAGR 45.68% (2025-2033). Investment score 73.5/100 (confidence 0.71). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
Orion Transports — 移动遥测数据集商机
View opportunity →医疗保健Pixee Medical — 医疗影像数据集机会
View opportunity →工业Lancey — 工业传感器数据集机会
View opportunity →